Medios

Singapore, Singapore Founded: 2017 • Age: 9 yrs
Diabetic retinopathy is detected via AI analysis of fundus images.
Annual revenue $154,528 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Medios

Medios is a company based in Singapore (Singapore) founded in 2017 by Bhargav Sosale and Florian Savoy. Medios operates in a competitive market with competitors including Change Healthcare, AIdoc, HeartFlow, Cleerly and Median, among others.

  • Headquarter Singapore, Singapore
  • Founders Bhargav Sosale, Florian Savoy
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Medios Technologies Pte. Ltd.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $154.53 K (USD)
    204
    as on Dec 31, 2020
  • Net Profit
    $11.3 K (USD)
    118
    as on Dec 31, 2020
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Medios

Premium access

Detailed funding history for Medios

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Medios

Investments
Premium access

Investment portfolio details for Medios

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Medios

Premium access

Detailed financials for Medios

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Medios Comparisons

Medios Primary company
Description
Diabetic retinopathy is detected via AI analysis of fundus i...
Location
Singapore, Singapore
Founded Year
2017
Annual Revenue
$154.53 K (USD)
Net Profit
$11.3 K (USD)
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Medios

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Medios

Medios operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, HeartFlow, Cleerly and Median, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
Locked Locked Locked
AI-based single-screen system is provided to streamline medical imaging.
Locked Locked Locked
Cardiovascular diagnostics are provided using CT scans and analytics.
Locked Locked Locked
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
Locked Locked Locked
Medical imaging software and services are provided for clinical trials.
Locked Locked Locked
Provider of AI-based solution for diagnosis of cancer related lesions
Premium access

Detailed competitors of Medios

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Medios

Premium access

Complete news archive for Medios

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medios

Medios was founded in 2017.

Medios is headquartered in Singapore, Singapore.

Annual revenue of Medios is $154.53K as on Dec 31, 2020.

Medios was founded in 2017 in Singapore. An AI-based solution is offered for detecting diabetic retinopathy within the health technology sector. Fundus images are graded through automated analysis, and detailed reports are produced to support clinical assessments. Early identification of vision loss is facilitated for patients with diabetes. Operations focus on medical imaging tools to aid healthcare providers in routine screenings.

Medios's top competitors include Change Healthcare, AIdoc and eCential Robotics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available